Brain insulin spray tested during exercise in overweight volunteers
NCT ID NCT07466173
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how insulin delivered to the brain (via nasal spray) changes the immune system's response to exercise in overweight individuals. Eight participants will bike while receiving either insulin or a placebo spray. The goal is to understand the link between brain insulin resistance and immune function during physical activity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intranasal insulin spray
What this could lead to
If it works, this could help explain how brain insulin resistance affects immune responses during exercise in overweight individuals.
What could go wrong
This is a very small, early-stage study (8 people) that only measures short-term effects. It may not lead to any treatment or apply to the general population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN SENSITIVITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ulm University Hospital
Ulm, 89081, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••